Skip to content
10-Q

Quarterly Report

Translate Bio, Inc.

0001193125-20-136205

← back to feed
Filed
May 7, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 5, 2020 62.91M sh
Short Term Investments Q1 2020 · Mar 31, 2020 $57.63M
Short Term Investments Q1 2020 · Dec 31, 2019 $104.1M
Current Liabilities Q1 2020 · Mar 31, 2020 $41.11M
Current Liabilities Q1 2020 · Dec 31, 2019 $41.67M
Total Liabilities Q1 2020 · Mar 31, 2020 $162.57M
Total Liabilities Q1 2020 · Dec 31, 2019 $182.67M
Current Assets Q1 2020 · Mar 31, 2020 $169.19M
Current Assets Q1 2020 · Dec 31, 2019 $203.62M
Total Assets Q1 2020 · Mar 31, 2020 $305.24M
Total Assets Q1 2020 · Dec 31, 2019 $336.2M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $84.58M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $62.43M
Capex Q1 2020 · Mar 31, 2019 $1.04M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$21.53M
Stockholders Equity Q1 2020 · Mar 31, 2019 $95.11M
Stockholders Equity Q1 2020 · Dec 31, 2018 $125.3M
Sga Expense Q1 2020 · Mar 31, 2019 $6.55M
Rd Expense Q1 2020 · Mar 31, 2019 $17.42M
Net Income Q1 2020 · Mar 31, 2019 −$33.2M
Operating Income Q1 2020 · Mar 31, 2019 −$34.21M
Revenue Q1 2020 · Mar 31, 2019 $1.47M